Tag Archives: BIOTRONIK SE & Co. KG

Successful HBI and BIOTRONIK Partnership Saves 1,000 Lives – Now Reaching Out to More Countries

BIOTRONIK Renews Commitment After Achieving Their First Milestone of Providing 1,000 Life Saving Devices One Year Earlier Than Expected

BERLIN–(Marketwire/Asianet-Pakistan – October 1, 2012) –  BIOTRONIK, a leading manufacturer of innovative medical technology, has surpassed its commitment to provide life-saving devices to more than 1,000 economically disadvantaged patients by 2013 earlier than anticipated. Through its partnership with Heartbeat International Foundation, Inc. (HBI), BIOTRONIK delivered 776 pacemakers and 405 implantable cardioverter-defibrillators (ICDs) in nearly 20 countries to date. Moreover with renewed support from BIOTRONIK, HBI is now expanding its international network to create new operational heart centers in additional countries such as China, Ethiopia and Cambodia.

“Not only has BIOTRONIK set itself the ambitious goal of saving 1,000 lives together with us — and surpassed all expectations by providing the necessary devices almost a year early — the company has strengthened its commitment: BIOTRONIK is now supporting HBI in its efforts to expand their activities to other regions in the world and ship devices to even more countries,” explained Benedict S. Maniscalco, MD, Chairman and CEO of HBI. “The commitment made by BIOTRONIK in support of HBI’s mission has set a high bar for other manufacturers of cardiac implantable devices. We want to encourage these manufacturers to take notice and join HBI in its mission.”

Since 1984, HBI has been the global leader in providing devices that treat cardiac arrhythmias of patients in need — combating the world’s number one killer, cardiovascular disease. Estimates indicate that 82% of cardiovascular disease originates in low- and middle-income countries — and up to 3 million people die each year because they are unable to afford a pacemaker or ICD.

BIOTRONIK’s partnership with HBI is dedicated to reducing those preventable fatalities by providing top-of-the-line cardiovascular implantable devices and subsequent treatment to economically disadvantaged patients free of charge — regardless of age, gender, religion, culture or political persuasion.

“As a company that is known for its dedication to patients’ health, we see it as our duty to advance initiatives that give economically disadvantaged patients access to life-saving, high quality care,” said Christoph Böhmer, President International, BIOTRONIK. “BIOTRONIK’s donation of cardiac devices to HBI’s program is an important part of this commitment. Working with Heartbeat International Foundation, we are continuously looking for new ways to save even more patients. We are proud as a leading global manufacturer of cardiovascular therapies to support HBI and advance our alliance together.”

Worldwide New HBI Alliances
By way of the One Heart Global Cardiovascular Alliance, HBI is in partnering discussions with many other nonprofit organizations located in countries where HBI has not yet established operational heart centers. Among these nonprofit organizations are groups such as the Love-Heart Project in China, led by Professor Dayi Hu, one of China’s leading cardiologists, and the Pan-African Society of Cardiology and the African Heart Network — both of which cover multiple countries and have hundreds of physician members.

“HBI is grateful for BIOTRONIK’s continued support and is privileged to count them as a strategic partner in the expansion of our primary mission of providing comprehensive cardiovascular services through the Global Cardiovascular Alliance,” commented Maniscalco.

For more information about HBI, visit: www.heartbeatsaveslives.org

For more information about BIOTRONIK, visit: www.biotronik.com

About BIOTRONIK SE & Co. KG
As one of the world’s leading manufacturers of cardiovascular medical devices, with several million devices implanted, BIOTRONIK is represented in over 100 countries by its global workforce of more than 5,600 employees. Known for having its finger on the pulse of the medical community, BIOTRONIK assesses the challenges physicians face and provides the best solutions for all phases of patient care, ranging from diagnosis to treatment to patient management. Quality, innovation and reliability define BIOTRONIK and its growing success — and deliver confidence and peace of mind to physicians and their patients worldwide.

Contact
Sandy Hathaway
Senior Director, Global Communications
BIOTRONIK SE & Co KG
Woermannkehre 1
12359 Berlin
+49 (0) 30 68905 1602
sandy.hathaway@biotronik.com

EPIC Alliance Gets to “The Heart of the Matter” at ESC Congress 2012

BERLIN–(Marketwire/Asianet-Pakistan – September 10, 2012) – Female electrophysiologists from around the world gathered on August 28th, 2012 at the European Society of Cardiology Congress to attend the EPIC Alliance’s scientific session: “The Heart of the Matter.”

The EPIC Alliance (Electrophysiologist International Community Alliance) is a global network of female electrophysiologists that has been supported by BIOTRONIK since 2008 to address the staggeringly small number of women working in the field.

Through various programs, internationally conducted meetings and clinical study opportunities, the alliance aims to increase the number of women working in electrophysiology. The group currently consists of 100 female electrophysiologists from around the world and is the only alliance of its kind that champions women in electrophysiology.

The EPIC Alliance’s scientific session at the ESC Congress was chaired by Professor Jeanne E. Poole (University of Washington, USA) and Professor Carina Blomström-Lundqvist, (University Hospital, Uppsala, Sweden). Well-known electrophysiologists presented new research with a special focus on gender-specific topics.

Dr. Sabine Ernst (Royal Brompton Hospital, London, UK) talked in her presentation “Working in the EP lab: Radiation risks to you and your patients” about how radiation exposure is a significant concern in the medical community. Using data from research supported by the EPIC Alliance, Dr. Ernst’s findings were presented in two posters at the congress.

“Radiation exposure remains an occupational health risk for interventional cardiologists and recent research shows that cardiologists may suffer from an increased risk for genetic damage over time,” Dr. Ernst explains. “However, there are simple steps and safety measures, such as taking care of adequate protective shielding as well as lowering overall exposure time, which will prevent unnecessary radiation exposure for patients and operators.”

Professor Silvia G. Priori’s presentation at the scientific session addressed gender differences in inheritable disorders and discussed how gender is an undisputed modifier of the expressivity of inherited arrhythmogenic disorders. Professor Priori (University of Pavia, Italy) is a recognized pioneer in the field of inherited cardiovascular diseases and a clinical cardiologist who has achieved global recognition for her work on inheritable diseases. Professor Priori’s research aims to identify gender differences in cardiac disorders which will pave the way for new diagnostic techniques and treatments in the future.

Dr. Andrea Russo, Professor of Medicine at Cooper Medical School of Rowan University (Cooper University Hospital, New Jersey, USA), presented findings about the benefits of implantable cardioverter defibrillator (ICD) therapy in women. Dr. Russo investigated the gender differences in epidemiology and presentation of sudden cardiac arrest. She concluded reasons for gender differences in ventricular arrhythmias and potential differences in the impact of device therapy on outcome are currently unclear and warrant further investigation.

In addition to the scientific session, the EPIC Alliance held a networking dinner to give members the opportunity to discuss topics ranging from career development and research to advice related to achieving a healthy professional and private life balance.

“BIOTRONIK is committed to excellence in cardiology and electrophysiology, which is why we believe it is important to continuously discover and promote talent. Science and medicine cannot afford to have gender inequality and undiscovered talent in the field of electrophysiology, which is a growing but still a small discipline,” explains Christoph Böhmer, President International, BIOTRONIK. “To address this imbalance, the EPIC Alliance aims to raise awareness of opportunities available for women in electrophysiology and to overcome hurdles that hinder them from starting a career in this field of work. We support the EPIC Alliance as it offers a great platform for women in this profession to establish international contacts, network on various levels and discuss important research topics.”

For more information about the EPIC Alliance: www.epic-alliance.com

About BIOTRONIK SE & Co. KG

As one of the world’s leading manufacturers of cardiovascular medical devices, with several million devices implanted, BIOTRONIK is represented in over 100 countries by its global workforce of more than 5,600 employees. Known for having its finger on the pulse of the medical community, BIOTRONIK assesses the challenges physicians face and provides the best solutions for all phases of patient care, ranging from diagnosis to treatment to patient management. Quality, innovation and reliability define BIOTRONIK and its growing success — and deliver confidence and peace of mind to physicians and their patients worldwide.

For more information: www.biotronik.com

Contact Information

Contact:
Sandy Hathaway
Senior Director, Global Communications
BIOTRONIK SE & Co. KG
Woermannkehre 1
12359 Berlin
Tel: +49 (0) 30 68905 1602
E-Mail: sandy.hathaway@biotronik.com